NCT06651983

Brief Summary

This study is a cross-sectional study of patients with diabetes. The main purpose of this study is to explore the relationship between inflammatory indicators, but not limited to inflammatory indicators, and diabetes complications, in order to find early predictors and screen out high-risk groups.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,000

participants targeted

Target at P75+ for all trials

Timeline
15mo left

Started Jun 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Jun 2025Sep 2027

First Submitted

Initial submission to the registry

October 7, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

October 22, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

2.3 years

First QC Date

October 7, 2024

Last Update Submit

April 7, 2026

Conditions

Diabetes Mellitus

Outcome Measures

Primary Outcomes (1)

  • C-reactive protein

    Data on inflammatory markers measured during hospitalization were collected in international units. C-reactive protein was measured and reported by the clinical laboratory of Nanfang Hospital under the condition of fasting.

    In November-december 2024

Study Arms (1)

1.with complications 2.without complications

non-intervention

Eligibility Criteria

Age20 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Diabetic patients with or without complications

You may qualify if:

  • Patients with a normative diagnosis of type 2 diabetes
  • Age ≥20 years old, regardless of gender
  • From January 2018 to August 2023, he was treated in Nanfang Hospital

You may not qualify if:

  • In the acute infection phase
  • The researchers judged that it was not suitable to participate in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University

Guangzhou, Guangdong, 510515, China

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Central Study Contacts

Mengchen Zou Zou, Professor

CONTACT

+86 18688423756zoumc163@163.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 7, 2024

First Posted

October 22, 2024

Study Start

June 1, 2025

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2027

Last Updated

April 13, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations

CN(1)